MATERIALS AND METHODS

Materials
Unless stated, all reagents were from Sigma (St Louis, MO, USA), Boehringer (Mannheim, Germany) or Pharmacia (Uppsala, Sweden).
Meningioma cell culture
The cell culture reagents and materials were purchased from Gibco-BRL Life Technologies (Eggenstein, Germany), Seromed (Berlin, Germany), or Nunc (Wiesbaden, Germany). Tumour samples were obtained from 30 patients with intracranial meningiomas. Invasion was assessed by nuclear magnetic resonance, direct intraoperative observation of the tumour and surrounding tissue, and histological evaluation. Other cases in which the diagnosis of invasiveness was inconclusive were excluded from this study. The 19 non-invasive meningiomas were classified histologically according to the World Health Organization (Zülch, 1979) as meningotheliomatous (13), fibroblastic (two), transitional (three) and anaplastic (one). The 11 invasive meningiomas were classified as meningotheliomatous (four), fibroblastic (three), transitional (two), psammomatous (one) and anaplastic (one).
Meningioma cell culture was performed as previously described (Pagotto et al, 1995) . Briefly, meningioma tissue was rinsed three times in preparation buffer (137 mmol l -1 sodium chloride, 5 mmol l -1 potassium chloride, 0.7 mmol l -1 Na 2 HPO 4 , 15 mmol l -1 HEPES pH 7.3, 10 mmol l -1 glucose, 2.5 mg l -1 amphotericin-B, and 10 5 U l -1 penicilin-streptomycin) and then dissected into small pieces. The tissue fragments were incubated in preparation buffer with the addition of 1000 U ml -1 collagenase (Worthington Biochemical Corporation, Freehold, NJ, USA), 2 g l -1
hyaluronidase 4 g l -1 bovine serum albumin (BSA), 10 mg l -1
DNAase II and 1 g l -1 soybean trypsin inhibitor with gentle rocking at 37°C until dispersed. The cells were resuspended in culture medium: Dulbecco's modified Eagle's medium (DMEM) pH 7.3 containing 10% fetal calf serum, 2.2 g l -1 sodium hydrogen carbonate (NaHCO 3 ), 10 mmol l -1 HEPES, 2 mmol l -1 glutamine, 10 ml l -1 non-essential amino acids, 10 ml l -1 modified essential medium (MEM) vitamins, 5 mg l -1 insulin, 5 mg l -1 transferrin, 2.5 mg l -1 amphotericin-B, 10 5 U l -1 penicilin-streptomycin, 20 mg ml -1 sodium selenit, and 30 pmol l -1 T 3 (Henning, Germany). The cell viability was routinely over 90% as assessed by acridine orange-ethidium bromide staining. The cells were incubated for 1 week under 5% carbon dioxide atmosphere at 37°C and used at the first passage. The differentiation state of the cultures was routinely checked as previously described (Pagotto et al, 1995) . The culture medium was replaced by stimulation medium (DMEM pH 7.3 containing 2.2 g l -1 NaHCO 3 , 10 mmol l -1 HEPES, 2 mmol l -1 glutamine and 1 g l -1 BSA) for 24 hours. Then, 10 -8 mol l -1 all-trans-RA (Sigma, St Louis, MO, USA) was added. After 24 h, the medium was collected for zymographic analysis and total protein measurements. The cells were collected with citrate buffer and then used for in vitro invasion, migration and invasion assays. The cell viability after RA treatment was checked by acridine orange-ethidium bromide staining. Only concentrations higher than 10 -6 mol l -1 RA were found to be toxic for these cells.
In vitro invasion
The invasive potential of meningioma cells was analysed as we previously described for small-cell lung cancer cells (Missale et al, 1998) . Polycarbonate filters, with 8-µm pore size, in 24-transwell chambers were covered with 30 µg of Matrigel (Becton Dickinson, Heidelberg, Germany) and dried. Then 100 000 cells were added in DMEM containing 0.1% BSA to the inner section of the transwell. Fetal calf serum (0.5%) was used as chemoattractant in the outer chamber. After a 24-h incubation, the cells in the inner chamber were removed with a cotton swab. The cells attached to the bottom side of the membrane were fixed with 4% formaldehyde, stained with haematoxylin and counted. The cell counting was always performed by the same operator who had no previous knowledge of the clinical diagnosis.
Cell migration
The in vitro migration of meningioma cells was analysed as previously described (Ledda et al, 1997) . Twenty thousand cells were seeded in Boyden chambers on polycarbonate filters covered with 5 µg cm -2 collagen I or fibronectin. Fetal calf serum (0.5%) was used as a chemoattractant in the lower chamber. After a 24-h incubation, the cells in the inner chamber were removed with a cotton swab. The cells attached to the bottom side of the membrane were fixed with 4% formaldehyde, stained with haematoxylin and counted. In all cases the differences between treatments are statistically significant (P < 0.01, ANOVA combined with Scheffé's test). The last four cases correspond to invasive meningiomas. 32.9 ± 3.5 35 ± 4.2 6 82 ± 6.9 85 ± 5.7 7 87 ± 5.7 88 ± 4.3 8 28.6 ± 2.3 25 ± 3.5 9 69 ± 5.6 71 ± 7.6 a In all cases the differences between treatments are not significant (P < 0.01, ANOVA combined with Scheffé's test). The last three cases correspond to invasive meningiomas.
Short-term cell adhesion
Ten thousand cells per well were seeded into 96-well plates previously coated with collagen I or fibronectin (Becton Dickinson, Heidelberg, Germany). After a 3-h incubation, the plates were shaken for 1 min at 150 rpm and washed with phosphate-buffered saline (PBS) to remove any non-adherent cells. The attached cells were fixed with 4% formaldehyde, stained with haematoxylin and counted.
Zymographic analysis of gelatinases
Gelatinolytic activity was analysed as described (Ledda et al, 1997) using 10% polyacrylamide gels containing 0.2% gelatin.
Conditioned media obtained as described earlier were mixed with loading buffer containing 2.5% sodium dodecyl sulphate (SDS) and incubated for 30 min at room temperature before loading onto the gel. After electrophoresis at 4°C under non-denaturing conditions, the gels were washed as described (Ledda et al, 1997) . After staining with Coomassie blue R250, gelatinase activity was observed as clear zones of proteolysis against a blue background. Incubation of the gels in the presence of 20 mmol l -1 EDTA was performed to demonstrate the calcium ion and zinc ion dependence of the proteinase activity observed. Human fetal fibroblast (HFL-1) cells and melanoma cells (MDA-MB231) were used as positive controls (Ledda et al, 1997) .
Statistics
Statistics were performed using one-way analysis of variance (ANOVA) in combination with the Scheffé's test. The results are expressed as mean ± s.e.m.
RESULTS
Invasion, migration and adhesion in meningioma cells
The invasive potential of meningioma cells was measured in 30 different cell preparations. Different tumours showed different in vitro invasive potentials. The invasive ability of meningioma cells correlated with the clinical and histological parameters of invasion ( Figure 1A ). The invasive tumours showed the highest in vitro invasive potential, whereas the less aggressive ones showed significantly lower invasion rates ( Figure 1A ). We measured cell migration on ECM-coated membranes and found that the more aggressive meningiomas had higher migration rates on collagen I and fibronectin (Figure 1 B, C) . To study whether these differences in invasion and migration are related to the adhesion to ECM components we measured short-term cell adhesion to collagen I and fibronectin-coated plates (Palacek et al, 1997) . We found that the invasive meningiomas show significantly lower adhesion to ECM components than the benign ones (Figure 1 D, E) . Therefore, there is a positive correlation between the clinical manifestation of invasiveness, the in vitro invasive potential and the in vitro cell migration. Accordingly, there is a negative correlation between the clinical observations and the cell adhesion to collagen I and fibronectin substrates.
Gelatinase activity in meningiomas
Invasion requires the digestion of extracellular matrix components by matrix metalloproteinases (MMP). Among these, MMP-2 and MMP-9 are expressed early during the acquisition of the invasive phenotype and correlate with increased invasion and metastasis (Stetler-Stevenson et al, 1993; Stetler-Stevenson, 1996) . We analysed the activity of MMP-2 and MMP-9 by gelatine zymogram in 20 meningioma cell cultures (13 non-invasive and seven invasive). The different tumours displayed different gelatinase activity patterns (Figure 2) . The different bands were identified as proMMP-9, MMP-9, proMMP-2, and MMP-2. The 66-kDa band co-migrated with the proMMP-2 secreted by HFL-1 cells. The second band was confirmed as the active form of MMP-2 because it co-migrated with a positive control obtained from HFL-1-conditioned medium incubated with MDA-MB231 cells treated with Concanavalin A, which was shown to activate MMP-2. The identity of the bands as metalloproteinases was further confirmed by inhibition with EDTA (data not shown). The intensity of the bands or the presence of the active forms of the enzymes did not seem to correlate with the tumour invasion. Therefore, in meningiomas, gelatinase activity seems not to be a limiting step for the clinical manifestation of invasiveness.
RA inhibits meningioma invasion
RA treatment in low doses (10 -8 mol l -1 ) significantly inhibited in vitro invasion of meningioma cells as measured by Boyden chamber assays (Table 1 ). All the cases analysed (n = 10) showed this inhibitory response irrespective of the basal level of invasion or the clinical diagnosis. In the same conditions, retinoic acid did not produce any changes in cell viability or proliferation measured by thymidine incorporation, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) or vital staining (data not shown). This indicates that the inhibitory effects of retinoic acid are not due to a cytotoxic effect. In parallel, MMP-2 and MMP-9 activity was measured in 12 meningiomas of different types treated with RA ( Figure 3) . RA did not affect MMP-2 or MMP-9 activity in the same tumours which showed responses in in vitro invasion. Since metalloproteinase activity also depends on the secretion of tissue inhibitors of metalloproteinases (TIMPs) (Stetler-Stevenson, 1996) , we analysed by enzyme-linked immunosorbent assay the effects of RA on TIMP-1 expression. RA did not produce any effect on TIMP-1 expression in nine cases analysed (Table 2) . Therefore, MMP-2 and MMP-9 activity is probably not involved in the effects of RA on invasion.
RA inhibits meningioma cell migration
Besides digestion of ECM components, another step of the invasion process is cell migration. We studied the migration of meningioma cells on ECM substrates and the effects of RA. RA inhibited the migration of meningioma cells on Boyden chambers covered with collagen I and fibronectin, major components of the interstitial ECM (Table 3) . RA does not affect the migration on In all cases the differences between treatments are statistically significant (P < 0.01, ANOVA combined with Scheffé's test). The last four cases correspond to invasive meningiomas. 
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RA stimulates adhesion to the ECM
Cell migration depends on cell adhesion to the ECM. As an integrative and quantitative parameter, we measured short-term cell adhesion to ECM substrates (Palacek et al, 1997) . To rule out a direct effect of RA on cell adhesion at the level of the cell membrane we added 10 -8 mol l -1 RA just before the adhesion assay. No significant differences were observed in cell adhesion under these conditions (Table 4 ). This indicates that RA does not affect cell adhesion through a direct effect on the cell membrane. However, after a 24-h treatment, RA strongly increased short-term cell adhesion to collagen I and fibronectin in all the cases analysed (n = 10) ( Table 5 ). This enhanced adhesion to the ECM substrates is in agreement with the inhibition of cell motility observed in the migration and invasion assays.
DISCUSSION
In this study we examined the cellular mechanisms of invasion in human meningiomas and investigated the effects of RA on in vitro invasion, migration and adhesion. We report that the clinical manifestation of tumour invasion correlates with in vitro invasion, cell migration and a decreased adhesion of meningioma cells to ECM substrates. In addition, we demonstrate for the first time that RA inhibits in vitro invasion and migration of meningioma cells and these effects involve an increase in the adhesion to ECM components. Therefore, we speculate that RA could revert the invasive meningiomas to a non-invasive phenotype similar to the one of clinically non-invasive tumours.
RA has been shown to successfully inhibit tumour development in several models (Lotan, 1996) . It inhibits transformation and proliferation, induces differentiation and apoptosis in vitro, and inhibits tumour growth in vivo (Harisiadis et al, 1978; Bertram et al, 1983; McGarvey et al, 1990 ). Here we show that RA also affects later stages of tumour development such as migration and invasion. These effects could possibly involve an increased adhesion to the ECM components. Our results therefore provide further insight into the cellular mechanisms involved in the effects of RA on tumour development.
Tumour invasion is a complex multistep process that requires proteolysis of the ECM performed by MMPs, dynamic changes in cell adhesion and cell migration. MMP-2, MMP-9 and their inhibitor TIMP-1 which play an important role in the invasion of many aggressive types of cancer (Stetler-Stevenson et al, 1993) do not seem to be involved in meningioma invasion. RA has been shown to inhibit MMP expression in different cell types (Woessner, 1991) . However, in meningioma cells, RA did not produce any changes in MMP-2, MMP-9 or TIMP-1. Similar effects of RA on invasion without affecting MMP-2 and TIMP-1 expression were recently observed in melanoma cells (Jacob et al, 1998) . Although we cannot exclude the participation of other metalloproteinases, the changes in in vitro invasion produced by RA in meningioma cells are probably not due to a reduced degradation of the ECM. Moreover, the strong stimulation of cell adhesion and the reduced migration on ECM substrates indicate that RA mainly affects cell motility in meningiomas.
It is well established that RA causes craniofacial malformations when administered during development (Durston et al, 1989; Gale et al, 1996; Marshall et al, 1996; Morris-Kay and Sokolova, 1996) . These effects are produced by changes in the identity and migration patterns of the neural crest cells (Marshall et al, 1992) . It was previously shown that RA alters the proteoglycan composition of the ECM thereby affecting neural crest cell migration during development (Moro Balbas et al, 1993) . These results are in agreement with our observations that retinoic acid modifies the cell-substrate interactions in the neural crest-derived meningioma cells, probably by regulating the levels of integrin expression or the affinity for the ECM components.
We have previously shown that meningioma cells, in contrast to normal adult meninges, express an endothelin autocrine loop (Pagotto et al, 1995) . Endothelin signalling is necessary for the post-migratory proliferation of the neural crest cells but does not affect cell migration (Clouthier et al, 1998) . This embryonic regulatory system controls the normal development of the meninges and could play a role in the pathological transformation of meningiomas (Kurihara et al, 1994) . The similarity between meningioma cells and fetal meninges, together with the present results of the effects of RA on invasion and migration, support the concept that meningioma cells express a fetal genetic programme that could be involved in the mechanisms governing meningioma pathogenesis at the level of proliferation and invasion.
As in vitro invasion, migration and decreased adhesion to the ECM correlate with the clinical manifestation of invasiveness we conclude that retinoic acid induces a non-invasive phenotype in meningioma cells. This suggests that RA therapy may benefit patients with meningiomas, where complete surgical resection is not possible, and thus prevent the invasion of the normal surrounding tissue.
